Mannose-binding lectin: Biology and clinical implications

Internal Medicine Journal

Volumn 35, Issue 9, 2005, Pages 548-555

  Worthley, D L ^a   Bardy, P G ^b,c   Mullighan, Charles G ^b,c,d  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Collectins; Infection; Innate immunity; Mannose binding lectin; Polymorphism

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; MANNOSE BINDING LECTIN SERINE PROTEASE 1; MANNOSE BINDING LECTIN SERINE PROTEASE 2; MANNOSE BINDING LECTIN SERINE PROTEASE 3; POLYMER; RECOMBINANT PROTEIN; SERINE PROTEINASE; TETRAMER; TUBERCULIN; UNCLASSIFIED DRUG;

ALLELE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CLINICAL TRIAL; COMPLEMENT FIXATION; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG HALF LIFE; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INNATE IMMUNITY; MOLECULAR BIOLOGY; MYCOSIS; NONHUMAN; PASSIVE IMMUNIZATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN VARIANT; RECURRENT INFECTION; REVIEW; SUBSTITUTION THERAPY; TRIPLE HELIX; VIRUS INFECTION;

HUMANS; MANNOSE-BINDING LECTIN;

EID: 24744441296     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00908.x     Document Type: Review

References (64)

1. Miller ME, Seals J, Kaye R, Levitsky LC. A familial, plasma-associated defect of phagocytosis: a new cause of recurrent bacterial infections. Lancet 1968; II: 60-3.
2. Ikeda K, Sannoh T, Kawasaki N, Kawasaki T, Yamashina I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987; 262: 7451-4.
3. Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002; 12: 335-52.
4. Holmskov U, Thiel S, Jensenius JC. Collectins and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547-78.
5. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002; 56: 630-41.
6. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-20.
7. Mead R, Jack D, Pembrey M, Tyfield L, Turner M. Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Lancet 1997; 349: 1669-70.
8. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency-revisited. Mol Immunol 2003; 40: 73-84.
9. Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99: 3524-9.
10. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358: 614-18.
11. Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 2000; 165: 2637-42.
12. Summerfield JA, Taylor ME. Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim Biophys Acta 1986; 883: 197-206.
13. Kilpatrick DC, Stewart K, Allan EK, Mclintock LA, Holyoake TL, Turner ML. Successful haemopoietic stem cell transplantation does not correct mannan-binding lectin deficiency. Bone Marrow Transplant 2005; 35: 179-81.
14. Ryley NG, Heryet AR, Lu J, Reid KB, Fleming KA. Comparison between liver and serum concentrations of mannan binding protein. J Clin Pathol 1993; 46: 259-63.
15. Homann C, Garred P, Hasselqvist P, Graudal N, Thiel S, Thomsen AC. Mannan-binding protein and complement dependent opsonization in alcoholic cirrhosis. Liver 1995; 15: 39-44.
16. Downing I, Koch C, Kilpatrick DC. Immature dendritic cells possess a sugar-sensitive receptor for human mannan-binding lectin. Immunology 2003; 109: 360-4.
17. Morio H, Kurata H, Katsuyama R, Oka S, Kozutsumi Y, Kawasaki T. Renal expression of serum-type mannan-binding protein in rat. Eur J Biochem 1997; 243: 770-4.
18. Uemura K, Saka M, Nakagawa T, Kawasaki N, Thiel S, Jensenius JC et al. L-MBP is expressed in epithelial cells of mouse small intestine. J Immunol 2002; 169: 6945-50.
19. Wagner S, Lynch NJ, Walter W, Schwaeble WJ, Loos M. Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues. J Immunol 2003; 170: 1462-5.
20. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-505.
21. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003; 31: 453-7.
22. Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 1999; 353: 1049-53.
23. Garred P, Michaelsen TE, Bjune G, Thiel S, Svejgaard A. A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand J Immunol 1993; 37: 468-70.
24. Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI et al. and the Oxford Pneumococcal Surveillance Group. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002; 359: 1569-73.
25. Kronberg G, Weis N, Madsen HO, Pedersen SS, Wejse C, Nielsen H et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis 2002; 185: 1517-20.
26. Shi L, Takahashi K, Dundee J, Shahroor-Karni S, Thiel S, Jensenius JC et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004; 199: 1379-90.
27. Garred P, Madsen HO, Balslev U, Hofmann B, Pedersen C, Gerstoft J et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997; 349: 236-40.
28. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochem Biophys Acta 2002; 1572: 401-13.
29. Reading PC, Hartley CA, Ezekowitz RAB, Anders EM. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 1995; 217: 1128-36.
30. Yuen MF, Lau CS, Lau YL, Wong WM, Cheng CC, Lai CL. Mannose binding lectin gene mutations are associated with progression of liver disease in chronic hepatitis B infection. Hepatology 1999; 29: 1248-51.
31. Matsushita M, Hijikata M, Ohta Y, Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 1998; 29: 695-700.
32. Kilpatrick DC, Delahooke TE, Koch C, Turner ML, Hayes PC. Mannan-binding lectin and hepatitis C infection. Clin Exp Immunol 2003; 132: 92-5.
33. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653-6.
34. Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 2004; 126: 95-9.
35. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314: 1229-32.
36. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431-7.
37. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358: 637-8.
38. Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Molbak K et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001; 285: 1316-21.
39. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 2004; 30: 1438-45.
40. Garred P, Pressler T, Lanng S, Madsen HO, Moser C, Laursen I et al. Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 2002; 33: 201-7.
41. Bergmann OJ, Christiansen M, Laursen I, Bang P, Hansen NE, Ellegaard J et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003; 70: 91-7.
42. Kilpatrick DC, Mclintock LA, Allan EK, Copland M, Fujita T, Jordanides NE et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003; 134: 279-84.
43. Horiuchi T, Gondo H, Miyagawa H, Otsuka J, Inaba S, Nagafuji K et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005; 6: 162-6.
44. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA, Latouche A et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood 2002; 100: 3908-18.
45. Siassi M, Hohenberger W, Riese J. Mannan-binding lectin (MBL) serum levels and post-operative infections. Biochem Soc Trans 2003; 31: 774-5.
46. Davies EJ, Snowden N, Hillarby MC, Carthy D, Grennan DM, Thomson W et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 110-14.
47. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 1998; 41: 1663-8.
48. Horiuchi T, Tsukamoto H, Morita C, Sawabe T, Harashima S, Nakashima H et al. Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 2000; 1: 464-6.
49. Garred P, Madsen HO, Halberg P, Peterson J, Kronborg G, Svejgaard A et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2145-52.
50. Øhlenschlaeger T, Garred P, Madsen HO, Jacobsen S. Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004; 351: 260-67.
51. Graudal NA, Homann C, Madsen HO, Svejaard A, Jurik AG, Graudal HK et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 1998; 25: 629-35.
52. Kilpatrick DC. Mannan binding protein in sera positive for rheumatoid factor. Br J Rheumatol 1997; 36: 207-9.
53. Graudal NA, Madsen HO, Tarp U, Svejgaard A, Jurik G, Graudal HK et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000; 43: 515-21.
54. Kruse C, Rosgaard A, Steffensen R, Vanning K, Jensenius JC, Christiansen OB. Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 2002; 187: 1313-20.
55. Annells MF, Hart PH, Mullighan CG, Heatley SL, Robinson JS, Bardy P et al. Interleukins-1,-4,-6,-10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth. Am J Obstet Gynecol 2004; 191: 2056-67.
56. Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet 1998; 352: 959-60.
57. Saevarsdottir S, Oskarsson OO, Aspelund T, Eiriksdottir G, Vikingsdottir T, Gudnason V et al. Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk. J Exp Med 2005; 201: 117-25.
58. Ma Y, Uemura K, Oka S, Kozutsumi Y, Kawasaki N, Kawasaki T. Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding protein dependent cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1999; 96: 371-5.
59. Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet 1994; 21: 125-31.
60. Hoal-Van Helden EG, Epstein J, Victor TC, Hon D, Lewis L-A, Beyers N et al. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 1999; 45: 459-64.
61. Dahl M, Tybjaerg-Hansen A, Schnorr P, Nordestgaard B. A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199: 1391-9.
62. Jensenius JC, Jensen PH, Mcguire K, Larsen JL, Thiel S. Recombinant mannan-binding lectin (MBL) for therapy. Biochem Soc Trans 2003; 31: 763-7.
63. Valdimarsson H, Stefansson M, Vikingsdottir T, Arason GJ, Koch C, Thiel S et al. Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol 1998; 48: 116-23.
64. Valdimarsson H, Vikingsdottir T, Bang P, Saevarsdottir S, Gudjonsson JE, Oskarsson O et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol 2004; 59: 97-102.